`

Vaxcyte

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$862.5M
size-icon Size
201 - 500

Frequently Asked Questions About Vaxcyte

What does Vaxcyte do?+

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcytes lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFTM cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Companys system for producing difficult-to-make proteins and antigens is intended...

What is Vaxcyte's industry? +

Vaxcyte operates in the Biotechnology research industry.

What is Vaxcyte's revenue? +

Vaxcyte's revenue is 11m - 100m

What is Vaxcyte's company size? +

Vaxcyte has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.